A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan.
Gastric Cancer
; 24(6): 1320-1329, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-34050432
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Adverse Drug Reaction Reporting Systems
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Gastric Cancer
Journal subject:
GASTROENTEROLOGIA
/
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Japón
Country of publication:
Japón